We believe the key to treating neurodegenerative disease is to intervene early|David Kalergis,CEO,Diffusion Pharmaceuticals Inc 00:10:00
Advancements in the biotechnology, pharmaceutical, and medical industries don’t happen in a vacuum; they require collaboration between investors, scientists, and business leaders,” said David Kalergis, Chairman and CEO of Diffusion. “Diffusion was founded in that same spirit of collaboration, and at the 37th Annual J.P. Morgan Healthcare Conference, we’ll have the opportunity to share our progress with an even larger audience of leaders who can potentially work with us to fuel life and fight deadly conditions such as cancer and stroke.
